Medical Assistance in Dying Requests in Pain Clinic (MAiD)

January 30, 2025 updated by: Salem Anaesthesia Pain Clinic

Medical Assistance in Dying (MAiD) Requests in the Chronic Pain Clinic Setting

Terminally ill patients often suffer existentially. Terminally ill patients with existential pain may request medical aid in dying. The Canadian government legalized Medical Assistance in Dying (MAiD) for patients unforeseeable deaths. This prospective observational study examined chronic pain clinic patients' MAiD requests. The study assessed the patients' life quality and outcomes.

Study Overview

Detailed Description

Adult patients diagnosed with terminal or severe intractable illnesses frequently endure existential distress. Consequently, patients with terminal illnesses who experience existential distress may contemplate or seek medical assistance in dying (MAiD). In March 2021, the Government of Canada implemented amendments to the Criminal Code to authorize Medical Assistance in Dying (MAiD) for individuals whose natural death is not reasonably foreseeable.

This prospective observational study evaluated requests made for MAiD by patients in the chronic pain clinic setting. The study assessed the quality of life and natural outcomes of the patients.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Surrey, British Columbia, Canada, V3S 7J1
        • Salem Anaesthesia Pain Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients with chronic pain and disability, undergoing treatment in a pain clinic.

Description

Inclusion Criteria:

  • Adult patients with chronic pain and disability.

Exclusion Criteria:

  • Patients without physical disability.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Chronic pain and disability.
Adult patients with chronic pain and physical disability.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
How many years the patient lived after initial consultation
Time Frame: 3 years
How long the patient lived naturally after the initial consultation and request for MAiD.
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Olu Bamgbade, MD, FRCPC, Salem Anaesthesia Pain Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2021

Primary Completion (Actual)

January 23, 2025

Study Completion (Actual)

January 23, 2025

Study Registration Dates

First Submitted

January 23, 2025

First Submitted That Met QC Criteria

January 23, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 30, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • SalemAnes MAiD Request

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Data will be shared at the final publication.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Subscribe